Hi Recruiter,
@boy1 doesn't like me being too optimistic, apparently it doesn't help the share price.
I can only go on comparisons and our strengths and weaknesses.
I think $200m is too low and $400m would represent the right risk/reward ratio with some huge upside if we get the right partner in a JV.
We know our board have all the right credentials and it shows up in spades over time.
Hope I'm being pessimistic with the above and it's real MC appreciates to $1b.
- Forums
- ASX - By Stock
- FFX
- Possible Potential in two to three years.
Possible Potential in two to three years., page-74
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online